How can you not love something titled “Money, Mischief and Science.” It just smacks of intrigue and high stakes. And when the rest of the title is “What Have We Learned About Doing Stem Cell Research?” you have an altogether intriguing topic for a panel discussion. That panel – featuring CIRM’s own Dr. Geoff Lomax, … Continue reading How do you know if they really know what they’re saying “yes” to?
clinical trials
The Ogawa-Yamanaka Prize Crowns Its First Stem Cell Champion
A world of dark Imagine if you woke up one day and couldn’t see. Your life would change drastically, and you would have to painfully relearn how to function in a world that heavily relies on sight. While most people don’t lose their sight overnight, many suffer from visual impairments that slowly happen over time. … Continue reading The Ogawa-Yamanaka Prize Crowns Its First Stem Cell Champion
The best scientists always want to know more
Some years ago I was in the Wren Library at Trinity College, Cambridge in England when I noticed a display case with a cloth over it. Being a naturally curious person, downright nosy in fact, I lifted the cloth. In the display case was a first edition of Sir Isaac Newton’s Principia Mathematica and in … Continue reading The best scientists always want to know more
CIRM CAP Kickoff to New Clinical Trials
Alisha Bouge is the project manager for CIRM's Clinical Advisory Panels (CAPs) On the cusp of the official kickoff to football season, CIRM has had its own kickoff to celebrate. The first Clinical Advisory Panel (CAP) meeting took place on August 18, 2015 in Irvine, CA with Caladrius Bioscience, Inc. And just as every NFL … Continue reading CIRM CAP Kickoff to New Clinical Trials
Cell mate: the man who makes stem cells for clinical trials
When we announced that one of the researchers we fund - Dr. Henry Klassen at the University of California, Irvine - has begun his clinical trial to treat the vision-destroying disease retinitis pigmentosa, we celebrated the excitement felt by the researchers and the hope from people with the disease. But we missed out one group. … Continue reading Cell mate: the man who makes stem cells for clinical trials
Throwback Thursday: Progress to a Cure for ALS
Welcome to our new “Throwback Thursday” (TBT) series. CIRM’s Stem Cellar blog has a rich archive of stem cell content that is too valuable to let dust bunnies take over. So we decided to brush off some of our older, juicy stories and see what advancements in stem cell research science have been made since! … Continue reading Throwback Thursday: Progress to a Cure for ALS
Improving process drives progress in stem cell research
Process is not a sexy word. No one gets excited thinking about improving a process. Yet behind every great idea, behind every truly effective program is someone who figured out a way to improve the process, to make that idea not just work, but work better. It’s not glamorous. Sometimes it’s not even pretty. But … Continue reading Improving process drives progress in stem cell research
Stem cell stories that caught our eye: Parkinson’s trial revived, aspirin kills cancer stem cells and a stem cell role in mother-child obesity
Here are some stem cell stories that caught our eye this past week. Some are groundbreaking science, others are of personal interest to us, and still others are just fun. Parkinson’s clinical trials back on track. After nearly 20 years of being stuck on the clinical trial “bookshelf”, an international team from Cambridge, UK revived … Continue reading Stem cell stories that caught our eye: Parkinson’s trial revived, aspirin kills cancer stem cells and a stem cell role in mother-child obesity
Desperate patients and false hope: a troubling trend for stem cell-based therapies
A gambler’s odds are usually stacked against them but the possibility, however slim, of hitting the jackpot keeps bringing them back to the table. Now imagine, unbeknownst to them, the system is rigged so there’s a zero percent chance of any winnings. They’d essentially be giving their money away based on a false hope. Sadly, … Continue reading Desperate patients and false hope: a troubling trend for stem cell-based therapies
One man’s story points to hope against a deadly skin cancer
One of the great privileges and pleasures of working at the stem cell agency is the chance to meet and work with some remarkable people, such as my colleagues here at CIRM and the researchers we support. But for me the most humbling, and by far the most rewarding experience, is having a chance to … Continue reading One man’s story points to hope against a deadly skin cancer
The Stem Cellar 